| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | snRNA catabolic process | 1.29e-05 | 5 | 24 | 2 | GO:0016076 | |
| GeneOntologyBiologicalProcess | rRNA metabolic process | 1.40e-05 | 275 | 24 | 5 | GO:0016072 | |
| GeneOntologyBiologicalProcess | rRNA processing | 1.34e-04 | 230 | 24 | 4 | GO:0006364 | |
| GeneOntologyBiologicalProcess | negative regulation of protein modification by small protein conjugation or removal | 2.08e-04 | 100 | 24 | 3 | GO:1903321 | |
| GeneOntologyBiologicalProcess | negative regulation of post-translational protein modification | 2.33e-04 | 104 | 24 | 3 | GO:1901874 | |
| GeneOntologyCellularComponent | TRAMP complex | 1.26e-05 | 5 | 24 | 2 | GO:0031499 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 2.30e-04 | 503 | 24 | 5 | GO:0099572 | |
| GeneOntologyCellularComponent | nuclear speck | 1.37e-03 | 431 | 24 | 4 | GO:0016607 | |
| GeneOntologyCellularComponent | postsynaptic density | 1.61e-03 | 451 | 24 | 4 | GO:0014069 | |
| GeneOntologyCellularComponent | adherens junction | 1.78e-03 | 212 | 24 | 3 | GO:0005912 | |
| GeneOntologyCellularComponent | asymmetric synapse | 1.98e-03 | 477 | 24 | 4 | GO:0032279 | |
| GeneOntologyCellularComponent | perikaryon | 2.05e-03 | 223 | 24 | 3 | GO:0043204 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 2.76e-03 | 523 | 24 | 4 | GO:0098984 | |
| GeneOntologyCellularComponent | nuclear body | 3.19e-03 | 903 | 24 | 5 | GO:0016604 | |
| GeneOntologyCellularComponent | cell body | 3.60e-03 | 929 | 24 | 5 | GO:0044297 | |
| GeneOntologyCellularComponent | cell-cell junction | 4.28e-03 | 591 | 24 | 4 | GO:0005911 | |
| GeneOntologyCellularComponent | anchoring junction | 4.45e-03 | 976 | 24 | 5 | GO:0070161 | |
| GeneOntologyCellularComponent | postsynapse | 5.32e-03 | 1018 | 24 | 5 | GO:0098794 | |
| Domain | Plakophilin/d_Catenin | 3.03e-05 | 7 | 23 | 2 | IPR028435 | |
| Domain | Arm | 6.60e-04 | 31 | 23 | 2 | PF00514 | |
| Domain | RAS | 8.42e-04 | 35 | 23 | 2 | PS51421 | |
| Domain | Small_GTPase_Ras | 9.41e-04 | 37 | 23 | 2 | IPR020849 | |
| Domain | ARM | 1.10e-03 | 40 | 23 | 2 | SM00185 | |
| Domain | ARM_REPEAT | 1.10e-03 | 40 | 23 | 2 | PS50176 | |
| Domain | Armadillo | 1.52e-03 | 47 | 23 | 2 | IPR000225 | |
| Domain | SH3 | 2.28e-03 | 216 | 23 | 3 | PS50002 | |
| Domain | SH3 | 2.28e-03 | 216 | 23 | 3 | SM00326 | |
| Domain | SH3_domain | 2.40e-03 | 220 | 23 | 3 | IPR001452 | |
| Domain | Ras | 1.20e-02 | 136 | 23 | 2 | PF00071 | |
| Domain | - | 1.22e-02 | 746 | 23 | 4 | 3.40.50.300 | |
| Domain | Small_GTPase | 1.64e-02 | 160 | 23 | 2 | IPR001806 | |
| Domain | SH3_1 | 1.72e-02 | 164 | 23 | 2 | PF00018 | |
| Domain | Small_GTP-bd_dom | 1.78e-02 | 167 | 23 | 2 | IPR005225 | |
| Domain | LRR_8 | 1.86e-02 | 171 | 23 | 2 | PF13855 | |
| Domain | P-loop_NTPase | 1.88e-02 | 848 | 23 | 4 | IPR027417 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 9342840 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 1.25e-06 | 1257 | 24 | 8 | 36526897 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 10896674 | ||
| Pubmed | Interaction properties of human TRAMP-like proteins and their role in pre-rRNA 5'ETS turnover. | 1.37e-06 | 3 | 24 | 2 | 27434818 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 19706687 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 2.79e-06 | 605 | 24 | 6 | 28977666 | |
| Pubmed | 3.06e-06 | 615 | 24 | 6 | 31048545 | ||
| Pubmed | Chromosomal mapping of human armadillo genes belonging to the p120(ctn)/plakophilin subfamily. | 4.56e-06 | 5 | 24 | 2 | 9721216 | |
| Pubmed | 4.56e-06 | 5 | 24 | 2 | 10037471 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 7.79e-06 | 724 | 24 | 6 | 36232890 | |
| Pubmed | 8.52e-06 | 417 | 24 | 5 | 36537216 | ||
| Pubmed | 9.34e-06 | 425 | 24 | 5 | 21081503 | ||
| Pubmed | 9.56e-06 | 7 | 24 | 2 | 25009281 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.02e-05 | 759 | 24 | 6 | 35915203 | |
| Pubmed | 1.27e-05 | 8 | 24 | 2 | 11821434 | ||
| Pubmed | 1.52e-05 | 1247 | 24 | 7 | 27684187 | ||
| Pubmed | 1.58e-05 | 223 | 24 | 4 | 20020773 | ||
| Pubmed | 1.73e-05 | 483 | 24 | 5 | 36912080 | ||
| Pubmed | 1.90e-05 | 847 | 24 | 6 | 35850772 | ||
| Pubmed | 3.54e-05 | 274 | 24 | 4 | 34244482 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 3.70e-05 | 954 | 24 | 6 | 36373674 | |
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 3.95e-05 | 96 | 24 | 3 | 25948554 | |
| Pubmed | 4.74e-05 | 102 | 24 | 3 | 26584622 | ||
| Pubmed | The role of human ribosomal proteins in the maturation of rRNA and ribosome production. | 4.77e-05 | 15 | 24 | 2 | 18697920 | |
| Pubmed | 7.63e-05 | 334 | 24 | 4 | 30425250 | ||
| Pubmed | 8.27e-05 | 123 | 24 | 3 | 35583604 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 8.67e-05 | 678 | 24 | 5 | 30209976 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 9.74e-05 | 695 | 24 | 5 | 23602568 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | 1.03e-04 | 704 | 24 | 5 | 32994395 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 1.11e-04 | 714 | 24 | 5 | 28302793 | |
| Pubmed | 1.14e-04 | 23 | 24 | 2 | 25523391 | ||
| Pubmed | Nuclear Functions of Nucleolin through Global Proteomics and Interactomic Approaches. | 1.35e-04 | 145 | 24 | 3 | 27049334 | |
| Pubmed | 1.57e-04 | 403 | 24 | 4 | 35253629 | ||
| Pubmed | 1.59e-04 | 27 | 24 | 2 | 24550280 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.98e-04 | 1294 | 24 | 6 | 30804502 | |
| Pubmed | 2.41e-04 | 844 | 24 | 5 | 25963833 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 2.52e-04 | 1353 | 24 | 6 | 29467282 | |
| Pubmed | 2.85e-04 | 187 | 24 | 3 | 29777862 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 2.94e-04 | 475 | 24 | 4 | 31040226 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 3.21e-04 | 1415 | 24 | 6 | 28515276 | |
| Pubmed | 3.32e-04 | 197 | 24 | 3 | 32434143 | ||
| Pubmed | 3.55e-04 | 1442 | 24 | 6 | 35575683 | ||
| Pubmed | 3.73e-04 | 205 | 24 | 3 | 27976729 | ||
| Pubmed | Proteome-wide analysis of phospho-regulated PDZ domain interactions. | 3.86e-04 | 42 | 24 | 2 | 30126976 | |
| Pubmed | 3.89e-04 | 208 | 24 | 3 | 11790298 | ||
| Pubmed | 3.89e-04 | 208 | 24 | 3 | 22145905 | ||
| Pubmed | 4.28e-04 | 215 | 24 | 3 | 30462309 | ||
| Pubmed | 4.34e-04 | 1497 | 24 | 6 | 31527615 | ||
| Pubmed | The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. | 4.58e-04 | 220 | 24 | 3 | 34091597 | |
| Pubmed | 4.64e-04 | 46 | 24 | 2 | 16791210 | ||
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 4.64e-04 | 221 | 24 | 3 | 29991511 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 4.99e-04 | 989 | 24 | 5 | 36424410 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 5.28e-04 | 231 | 24 | 3 | 16452087 | |
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 5.76e-04 | 238 | 24 | 3 | 35864588 | |
| Pubmed | The human ribosomal protein genes: sequencing and comparative analysis of 73 genes. | 5.93e-04 | 52 | 24 | 2 | 11875025 | |
| Pubmed | Proteomic analysis of in vivo phosphorylated synaptic proteins. | 6.16e-04 | 53 | 24 | 2 | 15572359 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 6.21e-04 | 1038 | 24 | 5 | 26673895 | |
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 6.49e-04 | 248 | 24 | 3 | 27926873 | |
| Interaction | RBM4B interactions | 1.24e-05 | 262 | 24 | 5 | int:RBM4B | |
| Interaction | HNRNPU interactions | 1.66e-05 | 1035 | 24 | 8 | int:HNRNPU | |
| Interaction | CHD3 interactions | 2.03e-05 | 757 | 24 | 7 | int:CHD3 | |
| Interaction | WWP2 interactions | 3.96e-05 | 840 | 24 | 7 | int:WWP2 | |
| Interaction | USP36 interactions | 5.73e-05 | 599 | 24 | 6 | int:USP36 | |
| Interaction | MDM2 interactions | 9.64e-05 | 658 | 24 | 6 | int:MDM2 | |
| Interaction | RPL7A interactions | 1.15e-04 | 679 | 24 | 6 | int:RPL7A | |
| Interaction | MYCN interactions | 1.25e-04 | 1373 | 24 | 8 | int:MYCN | |
| Interaction | NLE1 interactions | 1.42e-04 | 228 | 24 | 4 | int:NLE1 | |
| Interaction | DDX21 interactions | 1.56e-04 | 718 | 24 | 6 | int:DDX21 | |
| Interaction | RPL3 interactions | 1.60e-04 | 722 | 24 | 6 | int:RPL3 | |
| Interaction | EFTUD2 interactions | 1.82e-04 | 1449 | 24 | 8 | int:EFTUD2 | |
| Interaction | PUM3 interactions | 2.15e-04 | 254 | 24 | 4 | int:PUM3 | |
| Interaction | FGFBP1 interactions | 2.25e-04 | 257 | 24 | 4 | int:FGFBP1 | |
| Interaction | MTREX interactions | 2.42e-04 | 262 | 24 | 4 | int:MTREX | |
| Interaction | RPL28 interactions | 2.51e-04 | 494 | 24 | 5 | int:RPL28 | |
| Interaction | RPL36 interactions | 2.75e-04 | 504 | 24 | 5 | int:RPL36 | |
| Interaction | RCVRN interactions | 2.82e-04 | 21 | 24 | 2 | int:RCVRN | |
| Interaction | KAT6A interactions | 2.90e-04 | 510 | 24 | 5 | int:KAT6A | |
| Interaction | PDZD2 interactions | 3.09e-04 | 22 | 24 | 2 | int:PDZD2 | |
| Interaction | ADAMTS13 interactions | 4.34e-04 | 26 | 24 | 2 | int:ADAMTS13 | |
| Interaction | RIOK1 interactions | 4.54e-04 | 562 | 24 | 5 | int:RIOK1 | |
| Interaction | SRSF1 interactions | 4.84e-04 | 570 | 24 | 5 | int:SRSF1 | |
| Interaction | SF3B1 interactions | 4.88e-04 | 571 | 24 | 5 | int:SF3B1 | |
| Interaction | GLDC interactions | 5.22e-04 | 321 | 24 | 4 | int:GLDC | |
| Interaction | SF3A3 interactions | 6.48e-04 | 340 | 24 | 4 | int:SF3A3 | |
| Interaction | CHD4 interactions | 6.54e-04 | 938 | 24 | 6 | int:CHD4 | |
| Interaction | SGSM2 interactions | 6.60e-04 | 32 | 24 | 2 | int:SGSM2 | |
| Interaction | TPT1 interactions | 6.84e-04 | 345 | 24 | 4 | int:TPT1 | |
| Interaction | RRS1 interactions | 6.84e-04 | 345 | 24 | 4 | int:RRS1 | |
| Interaction | ELF5 interactions | 6.88e-04 | 147 | 24 | 3 | int:ELF5 | |
| Interaction | MAGEB2 interactions | 7.14e-04 | 349 | 24 | 4 | int:MAGEB2 | |
| Interaction | RPL39 interactions | 7.15e-04 | 149 | 24 | 3 | int:RPL39 | |
| Interaction | EIF3A interactions | 7.61e-04 | 355 | 24 | 4 | int:EIF3A | |
| Interaction | SNRNP40 interactions | 8.01e-04 | 637 | 24 | 5 | int:SNRNP40 | |
| Interaction | RPS19 interactions | 8.13e-04 | 639 | 24 | 5 | int:RPS19 | |
| Interaction | RALGDS interactions | 8.35e-04 | 36 | 24 | 2 | int:RALGDS | |
| Interaction | HECTD1 interactions | 8.41e-04 | 984 | 24 | 6 | int:HECTD1 | |
| Interaction | SRP14 interactions | 8.53e-04 | 366 | 24 | 4 | int:SRP14 | |
| Interaction | UPF2 interactions | 9.12e-04 | 162 | 24 | 3 | int:UPF2 | |
| Interaction | SMC5 interactions | 9.16e-04 | 1000 | 24 | 6 | int:SMC5 | |
| Cytoband | 2q24.1 | 9.12e-05 | 27 | 24 | 2 | 2q24.1 | |
| Cytoband | 1p22.1 | 1.29e-04 | 32 | 24 | 2 | 1p22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 2.01e-03 | 127 | 24 | 2 | chr2q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p22 | 2.34e-03 | 137 | 24 | 2 | chr1p22 | |
| GeneFamily | RAS type GTPase family | 3.81e-04 | 31 | 17 | 2 | 389 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.35e-04 | 43 | 17 | 2 | 409 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 8.23e-06 | 856 | 24 | 7 | M4500 | |
| Coexpression | GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_DN | 2.75e-05 | 194 | 24 | 4 | M9249 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_DN | 3.10e-05 | 200 | 24 | 4 | M3904 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 1.18e-04 | 179 | 24 | 3 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | Int-URO-Lymphocyte-B-B_naive|Int-URO / Disease, Lineage and Cell Type | 1.24e-04 | 182 | 24 | 3 | af7482c63e87a53cf686200a8f4d5b9749235dcd | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.26e-04 | 183 | 24 | 3 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-04 | 184 | 24 | 3 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-04 | 184 | 24 | 3 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-CMP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.32e-04 | 186 | 24 | 3 | 895905f1d1a01ffd5617a0baa8818693a7e9cb3b | |
| ToppCell | URO-Lymphocyte-B|URO / Disease, Lineage and Cell Type | 1.32e-04 | 186 | 24 | 3 | c46ff4fc280b67a454ee9614e93c6854a5a400b8 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 1.34e-04 | 187 | 24 | 3 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | URO-Lymphocyte-B-B_naive|URO / Disease, Lineage and Cell Type | 1.34e-04 | 187 | 24 | 3 | 9ed6a39aae7126ddbd01aec3376113b6b4517383 | |
| ToppCell | LAM-Lymphoid-B-cell-1|Lymphoid / Condition, Lineage and Cell class | 1.38e-04 | 189 | 24 | 3 | ceae675a769b0b01b9d0f27e9a21133959f7a7b3 | |
| ToppCell | facs-BAT-Fat-3m|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 189 | 24 | 3 | 7ce71f9c81512ed38c804f025908746b4af3aab1 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 1.38e-04 | 189 | 24 | 3 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | ILEUM-inflamed-(2)_Naive_B_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.41e-04 | 190 | 24 | 3 | a08d10f8145247d16c952a6f83957f5b57c6940b | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | 3639eb9b887a2d76949cad4a2586524fe0e1015f | |
| ToppCell | (4)_B_mantle|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.43e-04 | 191 | 24 | 3 | 5dab7f26c59838080787efad963b9cfcfa9a5f13 | |
| ToppCell | control-Lymphocytic-B_cells_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.45e-04 | 192 | 24 | 3 | f1ada2fb7f08d82c00bca2023481d975b0c2526f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.47e-04 | 193 | 24 | 3 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-B_lymphocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.47e-04 | 193 | 24 | 3 | ddc06227f2580774d9f34729dff912d6a9155f9c | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 194 | 24 | 3 | e74cd8cf3763f6adbfd1c269a886a806049714cf | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-04 | 194 | 24 | 3 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | ILEUM-inflamed-(2)_B_cell-(2)_Naive_B_cells|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.49e-04 | 194 | 24 | 3 | a89e67a40382600739be92e395bf47dd44aa4122 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-04 | 194 | 24 | 3 | dcf1b66f20ee9fe86de71221a086742140aa07d8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 195 | 24 | 3 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-Naive_B|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-04 | 195 | 24 | 3 | 537ca6df3a44bfde83c137f0c808a595c3dad892 | |
| ToppCell | normal_Lung-B_lymphocytes-Follicular_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.52e-04 | 195 | 24 | 3 | 2a9a2b36a9a4ce72a3b855c0872214f38a7c64b0 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-04 | 196 | 24 | 3 | ca54ed86453c1ac82de8b250455599e87aa5a7b7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37|World / Primary Cells by Cluster | 1.56e-04 | 197 | 24 | 3 | 00d756bc0231e1b3b88430214338c1059cb11106 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.56e-04 | 197 | 24 | 3 | 1c2e371231bb7c18b2dad3e551e54067f12cf7b0 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 197 | 24 | 3 | d9e196c8b4a6ede4733946dbdba3331534954beb | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 197 | 24 | 3 | 1da8ba5bbab232add6e43ad78b15c2339d0c2bc3 | |
| ToppCell | COVID-19_Severe-B_naive|COVID-19_Severe / disease group, cell group and cell class | 1.56e-04 | 197 | 24 | 3 | b8f18b39435e2229ba3bc07a25eb875d1ec11f6f | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 1.59e-04 | 198 | 24 | 3 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | mild-Myeloid-CD16_Monocytes|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.59e-04 | 198 | 24 | 3 | ba97ff6e9d400b53ad013dce54afd7154a0f4fc9 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.59e-04 | 198 | 24 | 3 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_PNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.59e-04 | 198 | 24 | 3 | 8de1808898e63cd74b131baeb9610e88363a41d1 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-B|Bac-SEP / Disease, condition lineage and cell class | 1.61e-04 | 199 | 24 | 3 | 1f4c9f4d227c79628de1f6c3fc05ab10217504a9 | |
| ToppCell | Severe-B_naive-4|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.61e-04 | 199 | 24 | 3 | e02e482cca6a00d2980e750bca6de598819aa1b2 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-B|ICU-NoSEP / Disease, condition lineage and cell class | 1.63e-04 | 200 | 24 | 3 | f8e08c74f3138eeb97a64ae495480114d2af5543 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_2_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.63e-04 | 200 | 24 | 3 | e6fea85df357731aad343e412672b5828403029f | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-B-B_naive|ICU-NoSEP / Disease, condition lineage and cell class | 1.63e-04 | 200 | 24 | 3 | 817c7e2108d54aa9c5f9ad6f59e2c1a84835f8f8 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B|Int-URO / Disease, condition lineage and cell class | 1.63e-04 | 200 | 24 | 3 | 9596e5f1a6cc7dfafc8d68ebd53ff32c41b06256 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-B-B_naive|Bac-SEP / Disease, condition lineage and cell class | 1.63e-04 | 200 | 24 | 3 | d377227314a4684d1bad15a13d87b1fa74b998f1 | |
| ToppCell | Sepsis-URO-Lymphocyte-B-B_naive|URO / Disease, condition lineage and cell class | 1.63e-04 | 200 | 24 | 3 | 0275c3f600e89c9700806642c8315de897f16a6d | |
| ToppCell | Sepsis-URO-Lymphocyte-B|URO / Disease, condition lineage and cell class | 1.63e-04 | 200 | 24 | 3 | d6839603145a222e6a74441630a4743fc35f8429 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-B_naive|Int-URO / Disease, condition lineage and cell class | 1.63e-04 | 200 | 24 | 3 | d2bf9792503fbe84f1dcac8c8ca02b504a07ab45 | |
| ToppCell | NS-control-d_0-4-Epithelial-Basal|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.21e-03 | 96 | 24 | 2 | 163268827cac146e57ea89e2d56c82aa1af4915e | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-03 | 98 | 24 | 2 | 95162072f3afc95e46f29db3d79ebd930bc09726 | |
| ToppCell | control-Epithelial-Basal|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.58e-03 | 110 | 24 | 2 | 192e056e4a75317dfa978997081485a9d9744a09 | |
| ToppCell | control-Epithelial-Basal|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.69e-03 | 114 | 24 | 2 | 276e32c2e04c4c060078cd5277ac5a9ae02033f8 | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Plasma_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 2.26e-03 | 132 | 24 | 2 | 4e37400ae7375e6986f060234c373194603346f8 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD8-positive,_alpha-beta_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.40e-03 | 136 | 24 | 2 | 9d7080f695de4ef183e3dbdc18ba464a3b8e3469 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT1_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-03 | 141 | 24 | 2 | b46ee98ed84ccb2696dcce40412f2d2288c677f4 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-4|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.61e-03 | 142 | 24 | 2 | 369f2e51e0283a4de70e6c7a3b95672c0838f205 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.68e-03 | 144 | 24 | 2 | ea174487f8ade90deb33b964a7f7e65062606565 | |
| ToppCell | Club_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.79e-03 | 147 | 24 | 2 | 5a824c89e4d045af465d7333275f8191fb29b041 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.79e-03 | 147 | 24 | 2 | d655e6ede8bca65a62efada2b15c7916e5f19324 | |
| ToppCell | Myeloid-Myeloid-C_(Monocyte)|Myeloid / shred on cell class and cell subclass (v4) | 2.79e-03 | 147 | 24 | 2 | d7cfec8ec1b4854d783a1bb07b4f8d2b2fd22893 | |
| ToppCell | (00)_Basal|World / shred by cell type and Timepoint | 2.87e-03 | 149 | 24 | 2 | 49e39206f37cee124ca4763c79425b805e50624b | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.87e-03 | 149 | 24 | 2 | a85a051e0d82430160967e72fa04b55f43e84513 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.90e-03 | 150 | 24 | 2 | 7a381f5ae94eba5eb60dcbf83416b4eb18c279ea | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 3.02e-03 | 153 | 24 | 2 | a156710217ef07c07a80ca6504fa0784d86380fa | |
| ToppCell | Control-PLT_4|World / Disease Group and Platelet Clusters | 3.06e-03 | 154 | 24 | 2 | a2a03c5e6759c45aeeedf1e68ecb5a0112ef9a20 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.06e-03 | 154 | 24 | 2 | 08ffa4b6f4a1c3de037acf9d30bd14c195738ad9 | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_LZ|tumor_Lung / Location, Cell class and cell subclass | 3.14e-03 | 156 | 24 | 2 | b5851474ba14dd2b4867415828b52dd98ecdd6d3 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.14e-03 | 156 | 24 | 2 | cea7b4f133272499e77ed451db91f699cff6a4bb | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-Teffector/EM_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 3.14e-03 | 156 | 24 | 2 | e308328f560c5ee7e9f95ac5db162f2d821ca39c | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-03 | 157 | 24 | 2 | 5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-03 | 157 | 24 | 2 | ad9c9b7dfeee3ae46e7e593c51a0407df12195b4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.18e-03 | 157 | 24 | 2 | a93866f051472506f1468f379c0d5313e02c9731 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC-DC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.21e-03 | 158 | 24 | 2 | 5d8a345df1d3001f34740b9f2f5f92f5428bbee6 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.25e-03 | 159 | 24 | 2 | 03d77e7fee40262bf0942aab96b273f1c4f5d8e3 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.25e-03 | 159 | 24 | 2 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.25e-03 | 159 | 24 | 2 | 0dccc4275b9b4f8554dd556da7218e130bff8fd1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.29e-03 | 160 | 24 | 2 | a76ad44b5f25f59d6b9333fb45f8bb96196a3090 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.29e-03 | 160 | 24 | 2 | af84da18c85037f49f55e8958f00f12140226982 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-03 | 160 | 24 | 2 | 03b88dc7ad41c6ae443cab7e77ec666340bf432e | |
| ToppCell | normal_Lung-T/NK_cells-Naive_CD8+_T|normal_Lung / Location, Cell class and cell subclass | 3.29e-03 | 160 | 24 | 2 | 97a4c69824e8708fbb12c468be1828d24a111db3 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.29e-03 | 160 | 24 | 2 | f7ca98beaa24f9674d503588eb15d341c4135d77 | |
| ToppCell | Severe-B_naive-11|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.34e-03 | 161 | 24 | 2 | ad3b58e3a8b59a609c8d2d2690d15218d18eabbd | |
| ToppCell | severe_influenza-CD4+_Tcm|World / disease group, cell group and cell class (v2) | 3.38e-03 | 162 | 24 | 2 | 7137990e6e1473665911e39a22092a05ae25ce74 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Proliferative_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.38e-03 | 162 | 24 | 2 | b24298910eb39ea5103ae24439b3901205ed55b6 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 3.42e-03 | 163 | 24 | 2 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | ILEUM-non-inflamed-(2)_B_cell-(2)_Naive_B_cells|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.42e-03 | 163 | 24 | 2 | 9add806d706f7170a49b2c2dcc14343e9befd26c | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD4_Naive|ICU-SEP / Disease, Lineage and Cell Type | 3.42e-03 | 163 | 24 | 2 | 415e67aaae7ccd97a003b4b31b27eed94737deca | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.42e-03 | 163 | 24 | 2 | cab65dabeea58141c649e4fec5e0123beb3de1b3 | |
| ToppCell | severe-Lymphocytic-B_cells_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.46e-03 | 164 | 24 | 2 | a1031e9f945a15186ee14c12be47aa11c3c6583b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.50e-03 | 165 | 24 | 2 | 4edc9714185a7519a7044487a3d6ea845131b851 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.50e-03 | 165 | 24 | 2 | fd1d38b97564c1f64f5c7246dcec96d60364b7b2 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial-RGCs_early_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.50e-03 | 165 | 24 | 2 | 1917f05a4050e28f669192e45023b0a31c53174b | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-MPP_myeloid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.50e-03 | 165 | 24 | 2 | dc70e050465d1f05bb4115356dc978aa581149b5 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Teffector/EM_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 3.50e-03 | 165 | 24 | 2 | ecaeb90a6bc27524ef6f2eefa72aec7315dbde3b | |
| ToppCell | NS-critical-d_0-4-Myeloid-Resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.50e-03 | 165 | 24 | 2 | 6b1c29dcef5a945786806ddbddddcec0023bd66e | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-03 | 166 | 24 | 2 | c1f18de4a1a2b6cdc703e6d29d136e1134fcbdf3 | |
| ToppCell | IIF-Lymphocyte-T_NK-CD8_TCM|IIF / Disease, Lineage and Cell Type | 3.54e-03 | 166 | 24 | 2 | f3f289eb9fa52abf0226ec711302022a07a6f345 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-03 | 166 | 24 | 2 | 94c30d6ca179d0cb02a5ed0093c5a2871e17ae50 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4|Liver / Manually curated celltypes from each tissue | 3.58e-03 | 167 | 24 | 2 | ab6273ae5d76a3f9a05c58320e3dee80f9b99e47 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.62e-03 | 168 | 24 | 2 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.62e-03 | 168 | 24 | 2 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-03 | 169 | 24 | 2 | 8dba7546adc6b1345933eec81fc77fc9611fae60 | |
| ToppCell | myeloid-Monocyte-CD14+_Monocyte|Monocyte / Lineage, cell class and subclass | 3.67e-03 | 169 | 24 | 2 | 7c3144a6599787f28662f5b22b8e45f4a115aeda | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 9.86e-05 | 19 | 23 | 2 | C1843181 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 9.86e-05 | 19 | 23 | 2 | C3501846 | |
| Disease | Costello syndrome (disorder) | 9.86e-05 | 19 | 23 | 2 | C0587248 | |
| Disease | Cardio-facio-cutaneous syndrome | 9.86e-05 | 19 | 23 | 2 | C1275081 | |
| Disease | LEOPARD Syndrome | 1.33e-04 | 22 | 23 | 2 | C0175704 | |
| Disease | Noonan Syndrome | 1.59e-04 | 24 | 23 | 2 | C0028326 | |
| Disease | suicide behaviour measurement | 5.15e-04 | 43 | 23 | 2 | EFO_0006882 | |
| Disease | tryptophan measurement | 6.68e-04 | 49 | 23 | 2 | EFO_0008534 | |
| Disease | C-reactive protein measurement | 2.06e-03 | 1206 | 23 | 5 | EFO_0004458 | |
| Disease | taste liking measurement | 3.29e-03 | 388 | 23 | 3 | EFO_0010155 | |
| Disease | chronotype measurement | 4.46e-03 | 882 | 23 | 4 | EFO_0008328 | |
| Disease | urate measurement | 4.70e-03 | 895 | 23 | 4 | EFO_0004531 | |
| Disease | insomnia measurement | 4.76e-03 | 443 | 23 | 3 | EFO_0007876 | |
| Disease | cardiovascular disease | 5.19e-03 | 457 | 23 | 3 | EFO_0000319 | |
| Disease | sporadic amyotrophic lateral sclerosis | 5.30e-03 | 140 | 23 | 2 | EFO_0001357 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.21e-03 | 152 | 23 | 2 | DOID:0060041 (implicated_via_orthology) | |
| Disease | risky sexual behaviour measurement | 7.62e-03 | 169 | 23 | 2 | EFO_0007877 | |
| Disease | macula measurement | 9.45e-03 | 189 | 23 | 2 | EFO_0008375 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.00e-02 | 195 | 23 | 2 | DOID:1574 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SEPSCWGKKKKKKKR | 781 | Q99569 | |
| WGKKKKKKKRTPQED | 786 | Q99569 | |
| RAEKKKKIKKYWAKK | 411 | Q8NFR7 | |
| SGCWGKKKKKKKSQD | 806 | Q9UQB3 | |
| EKSQKKKKKTKWRGD | 181 | O14807 | |
| VKKGYLLKKGKGKRW | 476 | P20936 | |
| SPWKKTGKNRKLKSK | 786 | O15055 | |
| EKGAYKKWGKSKKKC | 86 | Q92628 | |
| WDGKKALEAAKIKKK | 351 | P31644 | |
| KSGKLWCAKKNKKKR | 431 | Q8N3R9 | |
| WCAKKNKKKRKKVLY | 436 | Q8N3R9 | |
| GKAKGKLWLFGKKPK | 316 | Q5T0N5 | |
| KKIKRGLWGKYKLKK | 236 | P57773 | |
| GKRKGKSKKWKEILK | 21 | P34947 | |
| KEPAKEWKVLKKKKE | 536 | Q8N309 | |
| VKKRGWPKGKKRKKI | 51 | Q9P0W2 | |
| LTRKKNKKKKRFWKS | 26 | Q9GZR2 | |
| KRKDSLWKKLKGSLK | 196 | Q99578 | |
| LWKKLKGSLKKKREN | 201 | Q99578 | |
| KPKKEVKKKRWNRPK | 256 | P46777 | |
| SGGKAKKKKWSKGKV | 26 | P62851 | |
| KKKKWSKGKVRDKLN | 31 | P62851 | |
| WTVTGKKKNKKKKNK | 81 | Q86XZ4 | |
| AGTKKDKEKDKGKWK | 21 | P42285 | |
| KKKRKKDPSKGRWVE | 116 | O75554 | |
| KEGKRGKQKKKERCW | 511 | Q8N3Z6 | |
| KKKKPKKEEEQKWKW | 191 | P11387 | |
| KAKKGRRKLKLWKHS | 736 | Q9NR99 |